Michael T. Sheehan, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3501 Cranberry Blvd, Weston, WI 54476 Phone: 715-393-1000 |
News Archive
Nine out of ten Canadians believe biotechnology is important to Canada's future prosperity and eight out of ten supported grants to emerging companies, according to BIOTECanada's annual opinion poll, released at the launch of National Biotechnology Week.
TWi Pharmaceuticals, Inc., a specialty pharmaceutical company based in Taiwan, today announced its fully owned subsidiary, TWi Biotechnology, Inc. has completed a multinational phase II dose-ranging study of AC-201, an orally available IL-1 Beta modulator, in 259 patients with type II diabetes uncontrolled on up to three oral medications.
As Bahrain implements reforms following protests that started last year, a significant number of patients – from all political and religious backgrounds - continue to avoid seeking medical care in public hospitals due to perceived discrimination, harassment, and ill treatment, the international medical humanitarian organisation Médecins Sans Frontières said today.
Dialysis patients with low body fat are at increased risk of death-even compared to patients at the highest level of body fat percentage, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego.
› Verified 5 days ago